Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy - Concepedia

Concepedia

Publication | Open Access

Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy

DOI Full Paper Access

39

Citations

24

References

2011

Year

Dyah Aryani Perwitasari, Judith A.M. Wessels, R.J.H.M. van der Straaten, R. F. Baak-Pablo, M. Mustofa, Mehdi Hakimi, J.W.R. Nortier, Hans Gelderblom, Henk‐Jan Guchelaar

Japanese Journal of Clinical Oncology

Abstract

Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and vomiting.

References

	Year	Citations

Page 1